Results 271 to 280 of about 1,023,792 (288)

Meningococcal tetravalent conjugate vaccine

Expert Opinion on Biological Therapy, 2008
Neisseria meningitidis is a leading cause of meningitis and sepsis worldwide. Since 1981, a tetravalent meningococcal polysaccharide vaccine has been available in the US but it has been limited to high-risk patients and outbreak settings. In 2005, a tetravalent polysaccharide meningococcal conjugate vaccine (MCV4) was licensed for routine use in the US.
openaire   +3 more sources

Pneumococcal conjugate vaccines

The Pediatric Infectious Disease Journal, 1999
Merja Anttila, Juhani Eskola
openaire   +6 more sources

Impact of pneumococcal conjugate vaccines for children in high- and non–high-income countries

Expert Review of Vaccines, 2017
R. Cohen, Jérémie F. Cohen, M. Chalumeau, C. Levy   +3 more
semanticscholar   +1 more source

Conjugate Hib vaccines

The Lancet, 2003
David Goldblatt, Mark Steinhoff
openaire   +3 more sources

Conjugate vaccines and autism

Medical Hypotheses, 2011
openaire   +2 more sources

Pneumococcal conjugate vaccines

The Pediatric Infectious Disease Journal, 2000
openaire   +3 more sources

Serogroup A meningococcal conjugate vaccines in Africa

Expert Review of Vaccines, 2015
P. Kristiansen, H. Jørgensen, D. Caugant   +2 more
semanticscholar   +1 more source

Pneumococcal disease and conjugate vaccines

Enfermedades Infecciosas y Microbiología Clínica, 2018
Carmen Ardanuy, Jordi Càmara
openaire   +3 more sources

Preparation of Polysaccharide-Conjugate Vaccines

2003
Peeters, CC, Lagerman, PR, de Weers, O, Oomen, LA, Hoogerhout, Privm, Beurret, M, Poolman, JT, Reddin, KM   +7 more
openaire   +4 more sources

Effectiveness of pneumococcal conjugate vaccine

The Lancet, 2006
Orin S. Levine, Katherine L. O'Brien
openaire   +3 more sources